Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Department of Hematology, The Second Affiliated Hospital of Kunming Medical University.

NCT06073730 is registered in ClinicalTrials.gov with The Second Affiliated Hospital of Kunming Medical University as lead sponsor.

NCT NCT06073730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06073730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Department of Hematology, The Second Affiliated Hospital of Kunming Medical University.
Lead sponsor
The Second Affiliated Hospital of Kunming Medical University
Phase
Phase 3
Overall status
Completed
Start date
November 1, 2023
Completion date
April 30, 2026
Enrollment
154 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, decitabine, elderly aml patients, unfit, new-diagnosis aml, venetoclax